Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.0039 | 0.9 |
mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.0033 | 0.9 |
mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |
mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |
mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.0033 | 0.9 |
mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |